Item 2.02. Results of Operations and Financial Condition.

On August 12, 2021, Yumanity Therapeutics, Inc. (the "Company") issued a press release containing information about the Company's results of operations for the three and six months ended June 30, 2021. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits





99.1      Press release issued by Yumanity Therapeutics, Inc., dated August 12,
        2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses